| |
|
|
|
|
|
|
|||
|
Blood, 15 October 2006, Vol. 108, No. 8, pp. 2502.
Neutrophil chemotaxis: a tail of 2 GTPasesINDIANA UNIVERSITY SCHOOL OF MEDICINE
A study by Pestonjamasp and colleagues has identified Rac1, a Rho family GTPase, as an important link between the leading edge of migrating neutrophils and their uropod "tail," via activation of RhoA and myosin.
In the study by Pestonjamasp and colleagues, several approaches were used to show that communication between Rac and Rho to generate neutrophil polarity is more than simply a mutual antagonism. The results suggest that Rac, in particular the Rac1 isoform, also activates RhoA and myosin at the trailing edge of chemoattractant-stimulated neutrophils. The effects of activated or dominant-negative GTPases introduced into human neutrophils were analyzed, complemented by studies using murine neutrophils genetically deficient in either the Rac1 or Rac2 GTPases. Previous studies had shown that the 2 closely related Rac isoforms present in neutrophils, Rac1 and Rac2, play different roles in regulating chemoattractant-induced changes in neutrophil polarity. Neutrophils from Rac2-null mice have impaired chemotaxis due to a marked defect in lamellipodia formation, whereas neutrophils lacking Rac1 form multiple unstable lamellipodia and develop an elongated morphology due to a uropod retraction defect.1,2 In the current study, the introduction of dominant-negative Rac or dominant-negative Rho into human neutrophils produced a phenotype similar to Rac1-deficient mouse neutrophils. Additional studies showed that Rac, particularly Rac1, activity was coupled to Rho activation, which in turn was critical for myosin II contractility, tail retraction, and chemotaxis. Although genetic deletion studies in the murine system allow a relatively clean assessment of the relative functions of these 2 Rac isoforms, whether Rac1 plays a distinct role in regulating RhoA and uropod formation in human neutrophils remains unresolved. The amounts of Rac1 and Rac2 are similar in mouse neutrophils, whereas only 5% to 10% of the total Rac in human neutrophils is Rac1, with Rac2 accounting for the remainder. In addition, dominant-negative forms of Rac1 or Rac2 act by binding stably to Rac guanine nucleotide exchange factors to block Rac activation and lack selectivity for a particular Rac isoform.
The Cdc42 GTPase may also provide positive regulatory signals for Rho activation,3 and F-actin formation in the frontness response may help to limit the distribution of activated Rho.4 The organization of the lipid membrane itself also contributes to RhoA activation.5 A future challenge is to understand how these multiple underlying molecular events are linked to mediate chemoattractant-induced neutrophil polarization and movement. References
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||